253 related articles for article (PubMed ID: 21303421)
1. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation.
Wu H; Lee B; Yang L; Wang H; Givskov M; Molin S; Høiby N; Song Z
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):49-56. PubMed ID: 21303421
[TBL] [Abstract][Full Text] [Related]
2. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.
Alipour M; Omri A; Suntres ZE
Can J Physiol Pharmacol; 2011 Jun; 89(6):419-27. PubMed ID: 21815782
[TBL] [Abstract][Full Text] [Related]
3. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
Song Z; Moser C; Wu H; Faber V; Kharazmi A; Høiby N
J Cyst Fibros; 2003 Sep; 2(3):112-9. PubMed ID: 15463859
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
5. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
6. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
9. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
11. Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers.
Wang EW; Jung JY; Pashia ME; Nason R; Scholnick S; Chole RA
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):983-9. PubMed ID: 16301370
[TBL] [Abstract][Full Text] [Related]
12. Gerimax ginseng regulates both humoral and cellular immunity during chronic Pseudomonas aeruginosa lung infection.
Song Z; Wu H; Mathee K; Høiby N; Kharazmi A
J Altern Complement Med; 2002 Aug; 8(4):459-66. PubMed ID: 12230906
[TBL] [Abstract][Full Text] [Related]
13. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
15. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats.
Alipour M; Omri A; Lui EM; Suntres ZE
Can J Physiol Pharmacol; 2013 Nov; 91(11):935-40. PubMed ID: 24117261
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
18. Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung.
Musk DJ; Hergenrother PJ
J Appl Microbiol; 2008 Aug; 105(2):380-8. PubMed ID: 18284482
[TBL] [Abstract][Full Text] [Related]
19. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
20. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
